Remdesivir: US buys up almost entire world supply of coronavirus drug
The US has effectively secured the world’s supply of one of only two drugs proven to help treat coronavirus.
(Independent) – Remdesivir, which has previously been used to fight Ebola but has now been found to reduce recovery times among Covid-19 patients, is exclusively manufactured by pharmaceutical giant Gilead Sciences.
The US Department of Health and Human Services (HSS) has announced it has bought up more than 500,000 doses of the drug.
The figure equates to Gilead’s entire production for July, as well as 90 per cent of its production in both August and September.
The US’s decision to stockpile the drug means there will likely be little supply in the rest of the world for several months.